local_hospital

Familjeläkarna i Saltsjöbaden AB

Address
Byvägen 52, 133 34 Saltsjöbaden, Sweden

Bacterial Infections and Wound Care

At Familjeläkarna i Saltsjöbaden AB, clinical research in Bacterial Infections and Mycoses focuses on Diabetic Foot Ulcer care, with studies aimed at assessing how well local antimicrobial treatments support healing and infection control.

  • Evaluating treatment effectiveness for diabetic foot ulcers
  • Studying the role of local antimicrobial agents in complete wound healing

This area of research is especially relevant for improving outcomes in chronic wounds where infection can delay recovery and complicate care.

Respiratory Virus Research

Another part of the site’s portfolio covers Virus Diseases and Respiratory Tract Diseases, with a focus on RSV infection in older adults. The research is designed to better understand immune responses and support the evaluation of preventive strategies.

  • Assessing immune response after vaccination against RSV
  • Studying neutralizing antibodies in older adults

These studies help advance knowledge of respiratory virus protection, particularly for age groups at higher risk of severe illness.

Site Overview

assignment
2
connected trials
corporate_fare
3
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
3
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 188 other sites in Sweden

description
Trial volume
2
Outperforms 41% of sites
public
Therapeutic diversity
3areas
Outperforms 54% of sites
groups
Sponsor diversity
3sponsors
Outperforms 52% of sites

Therapeutic Area Benchmark — Sweden

Select a therapeutic area to compare against other sites in Sweden.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Sweden

Market Share

Country: Sweden

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Familjeläkarna i Saltsjöbaden AB

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Immunogenicity of Adjuvanted RSVPreF3 Vaccine in Elderly Patients Aged 80+ and 60-65 with RSV Infection: An Open-Label Phase IIIb StudyKarolinska InstitutetPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E1Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.